Sevoflurane and Laryngeal Mask Airway Versus Propofol Infusion and Facemask for EUA in Children

May 19, 2025 updated by: Cynthia Karam, American University of Beirut Medical Center

Comparison of Two Anesthetic Protocols (Sevoflurane and Laryngeal Mask Airway Versus Propofol Infusion and Facemask) for Eye Examination Under Anesthesia in Children

The goal of this clinical trial is to find out the optimal technique of anesthesia for eye examination in children. The main question it aims to answer is:

Is propofol infusion and simple oxygen facemask associated with earlier discharge from the operating room, and hence rapid turnover and greater efficiency compared to sevoflurane via LMA? Researchers will compare time to discharge from the operating room to see if eye examination for children less than 7 years using a propofol infusion pump based anesthesia and simple oxygen facemask results in a shorter discharge time from the operating room in comparison with sevoflurane via LMA.

Participants will will be assigned to receive general anesthesia by one of two treatment groups.

Study Overview

Detailed Description

Children younger than 5 years can be uncooperative during an examination and may render it impossible. The main objective of anesthesia for ophthalmic examination is to provide ideal conditions for optimal exam with a quick onset and offset of anesthesia as well as rapid recovery and early discharge. Two commonly used sedation techniques for young children are: sevoflurane via laryngeal mask airway (LMA) or propofol infused intravenously. Both have been shown to be safe and effective and allow rapid changes in anesthesia depth and minimal postoperative morbidity. However, their induction, emergence characteristics, and side effect profiles may differ. From previous studies, it is still not evident whether propofol infusion using oxygen facemask or sevoflurane administration via LMA is superior with respect to earlier discharge from operating room in children undergoing eye examination under anesthesia (EUA).

In the literature, there are no studies directly comparing those two different techniques for ophthalmic examination.

The aim of this study is to find out the optimal technique of anesthesia for eye examination in children resulting in earlier discharge from the operating room thus decreasing the turnover time between cases and providing optimal surgical conditions, without interfering with the well-being of the child or compromising the airway security.

In a prospective randomized study, a total sample of 60 children scheduled for eye examination under anesthesia (30 in each arm of the study) aged between 1-7 years with American Society of Anesthesiologists physical status 1 to 3 will be assigned to receive general anesthesia by one of two treatment groups. After induction with sevoflurane 8% in oxygen, patients randomized to group S will be given propofol 2 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with sevoflurane via LMA. Patients randomized to group P will be given propofol 1 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with a continuous infusion of propofol 200 µg/kg/min with oxygen 3 L/min via simple mask and oral airway if needed. In both groups sevoflurane concentration or propofol infusion will be titrated to keep optimal conditions. The primary outcome is time to discharge from the operating room. Secondary outcomes are surgical conditions, respiratory events, agitation and other side effects as well as recovery times. Normally distributed data will be summarized as mean ± SD and nonnormally distributed data will be summarized as median [interquartile range].

It is believed that propofol infusion and simple oxygen facemask will be associated with earlier discharge from the operating room, and hence rapid turnover and greater efficiency compared to sevoflurane via LMA. This study would have an impact on the current practice for pediatric ophthalmic EUA and may help find out the best technique that decreases the turnover time between cases resulting in higher operating time efficiency while providing optimal surgical conditions and patients' safety.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beirut, Lebanon
        • American University of Beirut Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children presented to the Operating Room of the American University of Beirut Medical Center
  • 1 to 6 years old
  • With American Society of Anesthesiologists physical status 1-3
  • Scheduled for ophthalmic EUA with or without laser/cryotherapy procedure

Exclusion Criteria:

  • Children with full stomach or significant aspiration risk (including hiatal hernia)
  • Children who are morbidly obese or have a current upper respiratory tract infection
  • Children who have oropharyngeal pathology (e.g., radiotherapy for hypopharynx/larynx), tracheostomies, or a family history of malignant hyperthermia
  • Children of parents who refuse to give consent
  • Children having allergy to the anesthetics used
  • Any surgical procedure expected to last for more than 60 minutes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group S
Group S will be given propofol 2 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with sevoflurane via LMA
In Group S, co-induction is used whereby the patient continues to receive 8% sevoflurane through the facemask followed after IV insertion by propofol 2mg/kg and fentanyl 1mic/kg administration. Thirty seconds afterwards, an age-appropriate LMA will be inserted. Sevoflurane is maintained initially at a concentration of 2%. The ventilation at first is assisted manually until the child starts breathing. If movement requires interruption of the exam, a bolus of propofol 1mg/kg is given and sevoflurane is increased by 1% until a maximal sevoflurane concentration of 4%. If apnea related to the depth of anesthesia occurs more than 10 sec or the saturation drops below 94%, sevoflurane will be turned off until the proper airway intervention is taken to achieve saturation above 95% and sevoflurane will be resumed at a concentration decreased by 1%.
Experimental: Group P
Patients randomized to group P will be given propofol 1 mg/kg and fentanyl 1µg/kg intravenously and anesthesia will be maintained with a continuous infusion of propofol 200 µg/kg/min with oxygen 3 L/min via simple mask and oral airway if needed.

In group P, the sevoflurane will be discontinued, and propofol 1 mg/kg and fentanyl 1µg/kg will be administered IV. Propofol pump is maintained initially at a rate of 200mic/kg/min. with oxygen at 3 liters/min via facemask.

If movement requires interruption of the exam, a bolus of propofol 1mglkg is given and the infusion rate is increased by 20mic/kg/min up to a maximal rate of 350mic/kg/min. The total number of boluses needed will be recorded as the need for additional sedation. If apnea related to the depth of anesthesia occurs more than 10 sec or the saturation drops below 94%, the infusion pump will be stopped until the proper airway intervention is taken to achieve saturation above 95% with spontaneous breathing. Afterwards, the propofol pump will be resumed at a rate decreased by 20mic/kg/min.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to discharge from the operating room
Time Frame: Time from the end of surgery to discharge from OR, assessed up to 40 minutes
Time to discharge from the operating room in minutes
Time from the end of surgery to discharge from OR, assessed up to 40 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of anesthesia
Time Frame: From the start till the end of anesthesia, assessed up to 120 minutes
Duration of anesthesia in minutes
From the start till the end of anesthesia, assessed up to 120 minutes
Duration of surgical procedure
Time Frame: From the start of eye examination till the completion of the procedure, assessed up to 60 minutes
Duration of surgical procedure in minutes
From the start of eye examination till the completion of the procedure, assessed up to 60 minutes
Ophthalmologist satisfaction score
Time Frame: During the procedure
Ophthalmologist satisfaction score measured on likert scale (ranging from 1 till 5 with 1 representing the least degree of satisfaction and 5 the highest).
During the procedure
Apnea
Time Frame: During the procedure
Apnea >10 seconds
During the procedure
Desaturation
Time Frame: During the procedure
SPO2<94%
During the procedure
Laryngospasm
Time Frame: During the procedure
Laryngospasm requiring treatment
During the procedure
Interruption
Time Frame: During the procedure
Number of interruptions of EUA
During the procedure
Emergence agitation
Time Frame: Immediately after the procedure
Emergence agitation on a four-point scale
Immediately after the procedure
Wake up time
Time Frame: Time from the end of anesthesia drug administration to spontaneous eye opening, assessed up to 180 minutes
Wake up time in minutes
Time from the end of anesthesia drug administration to spontaneous eye opening, assessed up to 180 minutes
PACU stay duration
Time Frame: Time from arrival to PACU till achievement of an Aldrete score of 9, assessed up to 180 minutes
PACU stay duration in minutes
Time from arrival to PACU till achievement of an Aldrete score of 9, assessed up to 180 minutes
Change in the airway management
Time Frame: Number of participants with change in airway management assessed by the data collector during the procedure
Change in the airway management
Number of participants with change in airway management assessed by the data collector during the procedure
Emesis
Time Frame: Number of participants who developed emesis, assessed by the data collector immediately after the procedure
Emesis
Number of participants who developed emesis, assessed by the data collector immediately after the procedure
Administration of pain medication
Time Frame: Number of participants who were administered pain medication, assessed by the data collector immediately after the procedure
Administration of pain medication
Number of participants who were administered pain medication, assessed by the data collector immediately after the procedure
Airway Obstruction
Time Frame: Number of participants who had an airway obstruction, assessed by the data collector during the procedure
Airway Obstruction
Number of participants who had an airway obstruction, assessed by the data collector during the procedure
Hypoventilation
Time Frame: Number of participants who developed hypoventilation, assessed by the data collector during the procedure
Hypoventilation
Number of participants who developed hypoventilation, assessed by the data collector during the procedure
Excess secretions
Time Frame: Number of participants who developed excess secretions, assessed by the data collector during the procedure
Excess secretions
Number of participants who developed excess secretions, assessed by the data collector during the procedure
Induction time
Time Frame: Time from anesthesia start to surgery start, assessed up to 60 minutes
Induction time in minutes
Time from anesthesia start to surgery start, assessed up to 60 minutes
Nonoperative time
Time Frame: Time from anesthesia start to surgery start combined with the time to discharge from OR, assessed up to 60 minutes
Nonoperative time in minutes
Time from anesthesia start to surgery start combined with the time to discharge from OR, assessed up to 60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cynthia Karam, MD, American University of Beirut Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2017

Primary Completion (Actual)

July 8, 2024

Study Completion (Actual)

July 8, 2024

Study Registration Dates

First Submitted

October 21, 2024

First Submitted That Met QC Criteria

October 22, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

May 22, 2025

Last Update Submitted That Met QC Criteria

May 19, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on sevoflurane via LMA

Subscribe